Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a multi‐center, double blind, randomized, placebo‐controlled, parallel‐group, phase 3 study. Subjects will be randomly assigned to one of the three treatment groups (DWP14012 A mg or DWP14012 B mg or placebo).
Epistemonikos ID: 69641f5d4f46371099c17244e1d01b2fd0c051aa
First added on: May 21, 2024